Investments
35Portfolio Exits
15Funds
2About Bridgescale Partners
Bridgescale Partners is a Silicon Valley-based private equity and venture capital firm that invests in U.S.-based, late-stage, technology-enabled companies. Bridgescale's investment focus includes growth equity in corporate spinouts, venture-backed and bootstrapped companies, middle market private equity investments, and management-led buyouts.
Bridgescale Partners Headquarter Location
2200 Sand Hill Road
Menlo Park, California, 94025,
United States
650-854-6100
Latest Bridgescale Partners News
Oct 1, 2019
Chronometriq secures $20M Series B led by Full In Partners In July 2017, Chronométriq raised over $3.5 million in Series A financing led by Bridgescale Partners. Founded in 2012, Montreal based Chronométriq is a leader in digital healthcare management through its suite of products enabling full-cycle appointment management for clinics and patients alike. photo credit: Chronométriq News Release Chronometriq Raises $20 Million in Series B Funding Round to Fuel Growth in the United States and Solidify Leadership Position in Canada MONTREAL, Oct. 1, 2019 /PRNewswire/ – Chronometriq, the Montreal-based provider of access-to-care and patient engagement tools, announced that the company has secured more than $20 million CAD in Series B funding. New York growth investor Full In Partners led the round with additional participation from existing investors. This financing will help further Chronometriq’s leadership position in Canada and give them significant opening traction in the United States. “We are very proud and excited to have attracted Full In as investors and partners in this round. During our process Full In stood out among 200-plus other firms for their compassion, value-add orientation, and long track record of partnering with founders to grow companies like ours” said Yan Raymond-Lalande, Co-Founder and CEO. “We’ve spent the last year in the U.S. optimizing our products and strategy for the market and have entered into an integration and distribution partnership with multiple major U.S. players. Thanks to our efforts and the operational support provided by Full In, we are now poised for successful expansion into the U.S., ” added Remi Richard, Co-Founder and Head of Growth. Elodie Dupuy, Co-Founder and Managing Director at Full In commented “The Chronometriq team has built an exciting suite of solutions that we think have the potential to transform healthcare for doctors and patients across North America. Yan and Remi immediately felt like family to us and ideal partners and we are so excited to be aligned in our pursuit of glory.” About Chronometriq (cMetricHealth, U.S.) Chronometriq, founded in 2012, was named one of the twenty-five most innovative businesses by C2-MTL. The company is a leader in digital healthcare management through its suite of products enabling full-cycle appointment management for clinics and patients alike. In the past year alone, Chronometriq served 12 million users through its network of clinics across North America. To learn more about Chronometriq, please visit: chronometriq.com. About Full In Partners Full In Partners is a new women-led growth equity fund based in New York, founded by Elodie Dupuy, Jess Davis and Eric Tonkyn. The firm is focused on changing the fundraising experience for entrepreneurs through the application of proprietary technology and value-add strategy, guidance, and relationships post-investment. To learn more about Full In, please visit: https://fullinpartners.com/ SOURCE Chronometriq Inc.
Bridgescale Partners Investments
35 Investments
Bridgescale Partners has made 35 investments. Their latest investment was in Finomial as part of their Series B on February 2, 2018.
Bridgescale Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
2/22/2018 | Series B | Finomial | $7.04M | No | 1 | |
12/11/2017 | Series B | BitGo | $42.5M | No | 9 | |
7/11/2017 | Series A | Pomelo Health | $2.7M | Yes | 3 | |
2/23/2016 | Series A - IV | |||||
1/13/2015 | Series A - III |
Date | 2/22/2018 | 12/11/2017 | 7/11/2017 | 2/23/2016 | 1/13/2015 |
---|---|---|---|---|---|
Round | Series B | Series B | Series A | Series A - IV | Series A - III |
Company | Finomial | BitGo | Pomelo Health | ||
Amount | $7.04M | $42.5M | $2.7M | ||
New? | No | No | Yes | ||
Co-Investors | |||||
Sources | 1 | 9 | 3 |
Bridgescale Partners Portfolio Exits
15 Portfolio Exits
Bridgescale Partners has 15 portfolio exits. Their latest portfolio exit was Finomial on October 26, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
10/26/2021 | Acquired | 7 | |||
5/5/2021 | Acquired | 13 | |||
4/20/2021 | Acq - Fin | 2 | |||
Date | 10/26/2021 | 5/5/2021 | 4/20/2021 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Acq - Fin | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 7 | 13 | 2 |
Bridgescale Partners Acquisitions
2 Acquisitions
Bridgescale Partners acquired 2 companies. Their latest acquisition was Incentium on October 23, 2008.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
10/23/2008 | Acq - Fin | |||||
3/10/2008 |
Date | 10/23/2008 | 3/10/2008 |
---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin | |
Sources |
Bridgescale Partners Fund History
2 Fund Histories
Bridgescale Partners has 2 funds, including Bridgescale Opportunities III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
12/22/2017 | Bridgescale Opportunities III | Diversified Private Equity | Closed | $4.1M | 1 |
12/31/2006 | Bridgescale Partners |
Closing Date | 12/22/2017 | 12/31/2006 |
---|---|---|
Fund | Bridgescale Opportunities III | Bridgescale Partners |
Fund Type | Diversified Private Equity | |
Status | Closed | |
Amount | $4.1M | |
Sources | 1 |
Bridgescale Partners Team
2 Team Members
Bridgescale Partners has 2 team members, including former Managing Director, Rob Chaplinsky.
Name | Work History | Title | Status |
---|---|---|---|
Matthew T. Cowan | Founder | Current | |
Rob Chaplinsky | Dryft, Mohr Davidow Ventures, H&Q Life Sciences Investors, and Intel | Managing Director | Former |
Name | Matthew T. Cowan | Rob Chaplinsky |
---|---|---|
Work History | Dryft, Mohr Davidow Ventures, H&Q Life Sciences Investors, and Intel | |
Title | Founder | Managing Director |
Status | Current | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.